Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01914848
Other study ID # MAPS Trial
Secondary ID
Status Completed
Phase N/A
First received November 26, 2012
Last updated June 3, 2016
Start date July 2013
Est. completion date August 2015

Study information

Verified date June 2016
Source University of Zurich
Contact n/a
Is FDA regulated No
Health authority Switzerland: Ethikkommission
Study type Interventional

Clinical Trial Summary

Multiprofessional Advance Care Planning and shared decision making for end of live care for terminal patients and their relatives.

The aim of this study is to develop, implement and test a complex intervention for improving patients' preparation for and participation in end of life decisions. In cooperation with local, national and international partners, the investigators will focus on strategies to enhance advance care planning and shared decision making on end of life issues, and documentation and transferability of end of life decisions across health care settings in coordinated approach involving patients, their families and care givers (in and out of hospital).


Recruitment information / eligibility

Status Completed
Enrollment 115
Est. completion date August 2015
Est. primary completion date April 2015
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion criteria: -patients in which the treating physician on the ward would not be surprised if the patient died during the next year (surprise question of Weissman et al 2011)

- male and female patients above 18 years of age

- signed informed consent after being informed

- patients able to appoint a surrogate decision maker (SM) and/or responsible physician to be contacted after discharge

Exclusion criteria: -patients not capable of speaking german

- patients having no responsible physician to be contacted after discharge and no relative/future surrogate decision maker (SM)

- inhouse patients being discharged within the next 2 days or ambulatory patients not regularly coming to the wards (at least every two month)

- patients assessed by their physician to be in obvious denial of their situation (illness/prognosis)

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Supportive Care


Related Conditions & MeSH terms


Intervention

Other:
Advance Care Planning ACP
Patient of the intervention group get a decision aid video and library and up to 3 consultations with qualified Advance Care Planning Facilitators.
Control Group
A routine care discharge planning with the social service

Locations

Country Name City State
Switzerland University Hospital Zurich, Clinical Ethics Zurich ZH

Sponsors (1)

Lead Sponsor Collaborator
University of Zurich

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary end of life wish on resuscitation known (if alive) or fulfilled(if dead) after 6 month by responsible physician and/or surrogate decision maker (SM) during 2 weeks six months after discharge No
Secondary end of live decisions on last place of care, antibiotics for pneumonia, feeding tube, intravenous fluids, dialysis, intubation and sedation, during 2 weeks six months after discharge No
Secondary decisional conflict scale ("DCS"), O Connor et al 1995 at discharge and during 2 Weeks six months after discharge No
Secondary Satisfaction with information and care, (see Detering et al 2010) at discharge No
Secondary Hospital Anxiety and Depression scale ("HADS") discharge and during 2 weeks six months after discharge No
Secondary Having an Advance directive at discharge, during 2 weeks three months after discharge and during 2 weeks six months after discharge No
Secondary Having an appointed surrogate decision maker at discharge, during 2 weeks three month after discharge and during 2 weeks six month after discharge No
Secondary Any hospital stay during 2 weeks three months after discharge and during 2 weeks six months after discharge No
Secondary Decisions regarding end of life issues already having been made/taken place during 2 weeks six months after discharge No
Secondary open question on important medical decisions being made during 2 weeks three months after discharge No
Secondary Treatment against patients wishes during 2 weeks three months after discharge and during 2 weeks six months after discharge, or 3 month after death Yes
Secondary Distress of Patients or relatives because of content of the consultation at discharge, during 2 weeks three months after discharge and during 2 weeks six months after discharge Yes
See also
  Status Clinical Trial Phase
Recruiting NCT05054647 - Mental Stress Symptoms in Family Caregivers of Palliative Patients